药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Heptabarbital
Aranidipine
The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Lenvatinib.
Heptabarbital
Pinaverium
The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Lenvatinib.
Heptabarbital
Trimebutine
The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Lenvatinib.
Heptabarbital
Vilanterol
The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Lenvatinib.
Heptabarbital
Flumequine
The risk or severity of QTc prolongation can be increased when Flumequine is combined with Lenvatinib.
Heptabarbital
Indenolol
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Lenvatinib.
Heptabarbital
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Lenvatinib.
Heptabarbital
Eribulin
The risk or severity of QTc prolongation can be increased when Eribulin is combined with Lenvatinib.
Heptabarbital
Bupranolol
The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Lenvatinib.
Heptabarbital
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Lenvatinib.
Heptabarbital
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Lenvatinib.
Heptabarbital
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Lenvatinib.
Heptabarbital
Histrelin
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Lenvatinib.
Heptabarbital
Buserelin
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Lenvatinib.
Heptabarbital
Degarelix
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Lenvatinib.
Heptabarbital
Pasireotide
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Lenvatinib.
Heptabarbital
Cariporide
The risk or severity of QTc prolongation can be increased when Cariporide is combined with Lenvatinib.
Heptabarbital
Amisulpride
The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Lenvatinib.
Heptabarbital
Vernakalant
The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Lenvatinib.
Heptabarbital
Tandutinib
The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Lenvatinib.